Loading organizations...
Loading organizations...

3i: Global investment manager specializing in private equity, infrastructure, and buyouts for mid-market companies in Europe and North America.
3i has raised $24.2M across 1 funding round.
Key people at 3i.
3i has raised $24.2M in total across 1 funding round.
3i Group is a multinational investment manager specializing in mid-market private equity and infrastructure that is based in London, England. The publicly listed firm targets growth-stage companies and small-to-medium enterprises across Northern Europe and North America, focusing on the consumer, healthcare, industrial technology, and business services sectors. As a constituent of the FTSE 100 Index, the organization operates with a market capitalization exceeding £28 billion and manages an investment portfolio valued at over £20 billion as of early 2024. The firm's private equity and infrastructure portfolio includes significant stakes in recognizable companies such as European discount retailer Action, ferry operator Scandlines, and aviation equipment provider TCR. Originally established as the Industrial and Commercial Finance Corporation, 3i Group was founded in 1945 by the Bank of England and major British clearing banks.
Key people at 3i.
3i has raised $24.2M in total across 1 funding round.
3i's investors include SV Investment, DS Asset Management, Enlight Ventures, Intops Investment, Korea Asset Investment Securities, Korea Development Bank, LB Investment, NBH Capital, YG Investment.
3i Group is a British multinational investment company specializing in private equity and infrastructure, primarily investing in mid-market companies across Europe and North America. Its mission is to generate attractive, long-term returns for shareholders by partnering with companies that benefit from structural growth trends, supporting them through disciplined investment and active management. Key sectors include consumer and private label, healthcare, industrials and services, and software. 3i plays a significant role in the startup and growth ecosystem by providing capital, strategic support, and international expansion opportunities to its portfolio companies, thereby driving sustainable growth and value creation[1][2][4].
Founded in 1945 originally as the Industrial and Commercial Finance Corporation (ICFC) by the Bank of England and major British banks, 3i was created to fill a financing gap for small and medium-sized enterprises. It evolved into a public limited company in 1987 and was listed on the London Stock Exchange in 1994. Over time, 3i has refined its focus to mid-market private equity and infrastructure investments, leveraging a long heritage and deep expertise. The firm’s key partners include a team of over 65 investment professionals across six countries, with a strong emphasis on local origination combined with international growth strategies[4][5].
3i capitalizes on structural growth trends such as digitalization, healthcare innovation, and consumer market evolution. The timing is favorable due to increasing demand for mid-market investment and the growing importance of sustainable and technology-driven business models. By backing companies that are scaling internationally and innovating digitally, 3i influences the broader ecosystem by enabling mid-sized firms to compete globally and adopt best practices in sustainability and operational excellence[1][3][5].
Looking ahead, 3i is poised to continue leveraging its thematic investment approach, focusing on sectors with strong growth potential and sustainability credentials. Trends such as digital transformation, healthcare advancements, and infrastructure development will shape its portfolio strategy. The firm’s influence is likely to expand as it deepens partnerships with portfolio companies, supports ESG initiatives, and navigates evolving market dynamics, maintaining its role as a key player in mid-market private equity and infrastructure investment[1][3][5].
3i has raised $24.2M across 1 funding round. Most recently, it raised $24.2M Series A in September 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 22, 2024 | TransMedics, Inc. | $29.8M Series C | 3i | — |
| Nov 22, 2024 | Wellpartner | $7.5M Series C | 3i, Buerk Dale Victor | — |
| Nov 21, 2024 | Endosense | $29.4M Other Equity | 3i, NeoMed Management | — |
| Nov 21, 2024 | Netronome | $20.0M Series C | 3i | — |
| Nov 21, 2024 | Coremetrics | $60.0M Series E | 3i | — |
| Dec 17, 2008 | Taptu | $10.0M Series B | 3i, Sofinnova Ventures | — |
| May 30, 2007 | AOptix Technologies | $15.0M Other Equity | DAG Ventures | Clearstone Venture Partners, Kleiner Perkins, Lehman Brothers |
| May 1, 2007 | AOptix Technologies | $15.0M Series C | DAG Ventures | Redpoint eventures, Tenaya Capital, Clearstone Venture Partners, Kleiner Perkins, Lehman Brothers |
| Dec 12, 2006 | Carbonite | $3.5M Series A | 3i | — |
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 3, 2021 | $24.2M Series A | SV Investment | DS Asset Management, Enlight Ventures, Intops Investment, Korea Asset Investment Securities, Korea Development Bank, LB Investment, NBH Capital, YG Investment |